120
Participants
Start Date
June 3, 2019
Primary Completion Date
August 1, 2024
Study Completion Date
July 31, 2025
CMV T cell Immunity Assay
Flow cytometry based assay quantifying IFN-gamma expression in T cells following CMV peptide stimulation (Viracor)
Albert Einstein College of Medicine/Children's Hospital at Montefiore, New York
University of Pittsburgh Medical Center/Children's Hospital of Pittsburgh, Pittsburgh
Children's Hospital of Philadelphia, Philadelphia
Duke University Medical Center/Duke Children's Hosptial, Durham
Emory University Medical Center/Children's Hospital of Atlanta, Atlanta
Vanderbilt University Medical Center, Nashville
Cincinnati Children's Hospital Medical Center, Cincinnati
Northwestern University Medical Center/Lurie Children's Hospital of Chicago, Chicago
Children's Mercy Hospital, Kansas City
University of Nebraska Medical Center, Omaha
Stanford University Medical Center/Lucile Packard Children's Hospital Stanford, Stanford
Boston Children's Hospital, Boston
ViraCor Laboratories
INDUSTRY
Vanderbilt University Medical Center
OTHER